Fact-checked by Grok 2 weeks ago

Erasmus MC

Erasmus MC, officially known as Erasmus University Medical Center, is a prominent academic and the medical faculty of in the . Founded in 2002 through the merger of several historic institutions dating back to 1840, it serves as the largest university medical center in the country, integrating advanced patient , cutting-edge research, and elite education to promote a healthy . With approximately 18,000 employees, it delivers top-clinical to over 192,000 patients annually, specializing in , , and acute medical conditions across its state-of-the-art 1,000-bed facility opened in 2018. The institution's research efforts are world-class and international in scope, aimed at understanding, predicting, treating, and preventing diseases through innovative biomedical and population-based studies. Erasmus MC also emphasizes with high-quality programs, including the innovative Erasmusarts 2030 designed for ambitious medical students, training around 4,500 biomedical students each year. Its strategic plan, Strategy28 (2024-2028), addresses pressing healthcare challenges while upholding core values of responsibility, connectivity, and enterprise. Financially robust with €2.5 billion in annual revenue and €700 million in recent investments for expansions like a and research tower, Erasmus MC continues to lead in medical innovation and societal impact.

Overview

Location and Facilities

Erasmus MC is situated in the heart of , , at Dr. Molewaterplein, in close proximity to the Museumpark cultural district. The medical center comprises three primary locations: the central hospital complex, which serves as the main hub for adult care; the Sophia Children's Hospital, dedicated to pediatric services; and the Daniel den Hoed Cancer Institute, specializing in treatment and research. These facilities are integrated within a compact campus, facilitating seamless patient transfers and multidisciplinary collaboration, with a total bed capacity of 1,233 across all sites. The infrastructure supports high-volume operations, including 39 operating theaters equipped for complex procedures and 121 beds to manage critical cases. Recent updates include the completion of major construction in 2018, which expanded and modernized patient wards, diagnostic areas, and support services to enhance efficiency and patient comfort. As an academic medical center affiliated with , the campus also accommodates educational spaces for integrated training. Looking ahead, the Masterplan 2050, approved by the Rotterdam municipal council in early 2025, outlines ambitious campus expansion with a strong emphasis on , including green roofs, rainwater storage, and energy-efficient buildings to support future growth in healthcare delivery through 2050. On a practical note, parking fees at Erasmus MC garages, such as those on Wytemaweg and Westzeedijk, increased as of January 1, 2025, in alignment with municipal policy to promote , with rates now starting at €4.20 for the first hour and a daily maximum of €40.

Role and Significance

Erasmus MC serves as the largest university medical center in the , functioning as the medical faculty of and integrating patient care, education, and scientific research to foster excellence in healthcare and . As one of eight such centers nationwide, it specializes in top-clinical treatment for complex cases, rare diseases, and acute conditions, while advancing educational programs and research initiatives that address pressing societal health challenges. The institution holds a prominent position in global assessments, ranking 52nd worldwide in the for Medical and , reflecting its strong performance in clinical, pre-clinical, and health-related disciplines. This standing underscores Erasmus MC's contributions to medical advancements and its leadership within the academic healthcare landscape. With approximately 18,000 employees as of 2024, Erasmus MC supports a vast operational scale dedicated to its mission. It also trains around 4,000 medical students, contributing significantly to the nation's supply of healthcare professionals. Erasmus MC extends its influence through national healthcare coordination, including ownership of the Admiraal de Ruyter Hospital in since 2017, which enhances regional access to specialized care and integrates peripheral services with its core expertise. Additionally, it leads networks such as the national NF1 shared care program, linking multiple treatment centers to standardize and improve care for specific conditions across the country.

History

Origins and Early Development

The origins of Erasmus MC trace back to 1840, when Rotterdam established its first municipal hospital, known as the Coolsingel Hospital, to address the growing healthcare needs of the city's expanding population during the industrial era. Commissioned to architect Willem Nicolaas Rose, the facility took 11 years to complete and opened in under the direction of Bastiaan Molewater, marking a significant advancement in organized public medical care in the . The Coolsingel Hospital served as Rotterdam's primary medical center for over a century, but it suffered catastrophic damage during the German bombardment of the city on , 1940, when four direct hits ignited a fire that destroyed most of the structure. In the ensuing post-World War II period, Rotterdam's population surged from around 587,000 in 1947 to 729,000 by 1960, driven by economic recovery and urban redevelopment, which intensified the demand for modern healthcare infrastructure. To accommodate this growth, the Dijkzigt Hospital was constructed and officially opened on September 18, 1961, at the former Land van Hoboken estate, named after the historic Van Hoboken family residence that once occupied the site. This new facility represented a major upgrade in capacity and technology, enabling better response to the city's healthcare challenges. Initial academic affiliations began in with the founding of the Faculty of Medicine and Health Sciences at what would become Erasmus University, integrating clinical training and research into hospital operations. In 1971, the Dijkzigt Hospital merged with the nearby Sophia Children's Hospital to form the , consolidating resources and establishing a unified medical framework that laid the groundwork for its modern university integration.

Formation and Modern Expansion

Erasmus MC was officially established on June 1, 2002, as a university medical center through the merger of the Rotterdam University Hospital—which encompassed the University Hospital Dijkzigt and Sophia Children's Hospital—the Daniel den Hoed Clinic, and the Faculty of Medicine and Health Sciences of . This integration created a unified dedicated to combining high-level patient care, , and , building on the hospitals' established roles in specialized treatment while formalizing ties. The formation addressed the need for a cohesive structure to handle growing demands in medical services and innovation in . Following its founding, Erasmus MC undertook significant physical expansions to modernize its infrastructure and enhance operational efficiency. Construction of a new central facility began in 2009, transforming the from a fragmented collection of buildings into a compact, integrated medical complex designed for better patient flow and . The project culminated in the facility's operational start in May 2018, with King Willem-Alexander officially opening the building on September 6, 2018; it features single-patient rooms, natural lighting, and energy-efficient designs to support advanced care for approximately 13,500 staff and thousands of daily visitors. These developments marked a pivotal step in Erasmus MC's evolution into a state-of-the-art hub for tertiary healthcare. In February 2025, the Erasmus MC Masterplan 2050 was approved by the Rotterdam municipal council, envisioning the campus as a hub for by integrating healthcare, , , and valorization through sustainable development and collaboration with partners up to 2050. As part of its ongoing alignment with —solidified during the 2002 merger—Erasmus MC has continued to deepen institutional integration through shared governance and collaborative initiatives in and . In 2024, the center adopted the Koers28 strategy for the period 2024–2028, which emphasizes transforming healthcare into a more accessible, sustainable, and balanced system by addressing societal challenges such as rising care demands and environmental impact. Key elements include advancing digital technologies like and e-health, reducing the in line with the Green Deal Sustainable Care, and fostering interprofessional under the Erasmus Arts 2030 vision to prepare future healthcare professionals. This forward-looking plan reinforces Erasmus MC's role within the university ecosystem while prioritizing innovative, patient-centered growth.

Organization and Governance

Leadership

The leadership of Erasmus MC is vested in its Executive Board, which handles day-to-day management and strategic implementation, while the provides oversight and approves key decisions such as budgets and major investments. The Executive Board consists of four members: Prof. Stefan Sleijfer serves as Chair and Dean, overseeing overall direction with a focus on , research, and patient care; he was reappointed in July 2025 for a five-year term by the . Dr. Joke Boonstra acts as Deputy Chair, managing operations in education and research; Dr. Paul Boomkamp is the (CFO), responsible for financial strategy and sustainability, reappointed in November 2024 for five years; and Ir. Dirk Schraven handles innovation, digitalization, and infrastructure projects. The , appointed by the Dutch Ministers of Education, Culture and and , and for renewable four-year terms, ensures compliance, advises on , and safeguards the interests of stakeholders including patients and staff. Current members include P.G. (Gijs) de Vries, alongside E.A. () Bakkum, M. (Mijntje) Lückerath-Rovers, R. (Roelof) Konterman, and J. () Verhagen. This dual-board structure facilitates collaborative strategic decision-making, aligning Erasmus MC's operations with national healthcare and academic priorities. The current governance framework traces its origins to the 2002 merger of Erasmus University's Faculty of Medicine and Health Sciences with Dijkzigt University Hospital, Sophia Children's Hospital, and the Daniel den Hoed Clinic, which unified leadership under a single Executive Board to integrate clinical, educational, and functions. Subsequent transitions, including appointments post-merger, have emphasized continuity in steering the institution's growth as a leading university medical center.

Administrative Structure

Erasmus MC's administrative structure is centered on integrating its three core missions—patient care, , and —through a network of over 50 departments and centers that facilitate multidisciplinary collaboration across these domains. Each department contributes to multiple missions, enabling seamless coordination between clinical operations, academic training, and scientific inquiry, with support from centralized administrative units for planning and policy implementation. This framework ensures that operational decisions align with the institution's goals of and excellence, overseen by the Executive Board for strategic direction. The clinical arm encompasses a wide array of specialized departments, including internal medicine (with subspecialties like allergology, cardiology, and nephrology), surgery (covering neurosurgery, cardiothoracic surgery, and pediatrics), oncology, neurology, radiology and nuclear medicine, anesthesiology, and pediatrics, among others. These departments deliver patient care through integrated facilities on the main Rotterdam campus, which includes the Dijkzigt Hospital for general and acute services, the Sophia Children's Hospital for pediatric specialties, and the Daniel den Hoed Cancer Institute for oncological treatments. Additionally, Erasmus MC integrates affiliated regional hospitals such as the Admiraal de Ruyter Hospital in Zeeland, acquired in 2017 to extend specialized care and support networks beyond Rotterdam, fostering a hub-and-spoke model for complex cases. Support services, including operating theaters and intensive care units, are distributed across these sites to enable efficient multidisciplinary teams comprising physicians, nurses, and allied health professionals. The educational arm is structured through dedicated units like the Department of Education Policy and Advice, which handles the organization, planning, and administration of medical training programs, and the Institute of Medical Education Research (iMERR), which focuses on advancing health professions education through evidence-based innovations. These units collaborate with clinical and research departments to embed teaching within daily operations, supporting undergraduate, graduate, and initiatives. The research arm operates via specialized centers and departments such as , , , and and infectious diseases, which conduct studies aligned with clinical priorities like rare diseases and . This division promotes interdisciplinary projects, with resources allocated to enhance from bench to bedside, all under the umbrella of the broader departmental structure.

Education

Undergraduate and Medical Training

The undergraduate medical training at Erasmus MC centers on the Bachelor of Medicine (Bachelor Geneeskunde), a three-year program that constitutes the initial phase of the six-year medical education pathway leading to and qualification as . This integrates foundational sciences such as , , biochemistry, and with introductory clinical skills, fostering a comprehensive understanding of human health and disease processes. Students engage in problem-based learning and small-group tutorials to develop critical thinking and interdisciplinary approaches essential for modern medicine. The program is taught in Dutch. In September 2024, Erasmus MC launched a restructured medicine program aligned with anticipated healthcare demands by 2030, incorporating enhanced emphasis on , patient-centered care, and through integrated modules and simulations. The program admits approximately 600-700 students annually via a selective national process, ensuring a diverse cohort prepared for evolving clinical challenges. Associated tracks within , offered through the three-year in , allow specialization in areas like , bioinformatics, , and , bridging basic research and clinical application. Erasmus MC also provides bachelor-level training for healthcare professionals, including a four-year program that combines theoretical coursework in patient care, ethics, and with practical placements. Allied health degrees, such as those in clinical technology and physiotherapy, span three to four years and focus on diagnostic tools, techniques, and interdisciplinary to support comprehensive patient management. These programs emphasize hands-on training in simulated and real-world settings to build competent practitioners. With approximately 4,500 biomedical students enrolled, including around 4,093 in medical training, Erasmus MC maintains a robust educational environment. Clinical rotations begin in the later bachelor years and intensify during the master's phase, occurring at Erasmus MC's university hospital and affiliated regional sites to provide exposure to diverse specialties like , , and under supervised conditions.

Graduate and Research Programs

The Erasmus MC Graduate School serves as the central hub for advanced in at , coordinating PhD and Research Master programs that bridge fundamental research with clinical applications. These programs emphasize interdisciplinary training in fields such as , molecular medicine, infection and immunity, , and health sciences, preparing students for careers in academic research, clinical innovation, and policy development. Admission typically requires a relevant bachelor's or , often with a strong foundation in life sciences or medicine obtained through undergraduate programs. The Research Master programs, lasting two years and culminating in a Master of Science (MSc) degree, provide in-depth scientific training through coursework, lab rotations, and thesis research. Examples include the Genomics in Society program, which explores ethical and societal implications of genomic technologies, and the Molecular Medicine track, focusing on disease mechanisms at the cellular level. PhD programs, structured as four-year tracks, build on this foundation with independent research under supervision, mandatory courses in research methodology, ethics, and specialized topics, and opportunities for international collaborations. The Graduate School supports numerous PhD candidates each year, fostering skills in data analysis, grant writing, and knowledge dissemination to address global health challenges, with over 250 PhD graduations annually as of 2019. Application cycles for these programs are annual, with deadlines typically in early spring for the following ; for instance, the 2024–2025 intake for Research Masters like Health Sciences closed on April 1, 2024, while positions are advertised continuously through departmental postings. Complementing these offerings, the Institute of Medical Education Research Rotterdam (iMERR) drives innovations in health professions by conducting rigorous studies on clinical reasoning, , and methods, while providing research internships and advanced training for MSc and students in . iMERR's work ensures evidence-based enhancements to graduate curricula, integrating with practical improvements in training healthcare professionals.

Research

Key Institutes and Focus Areas

Erasmus MC hosts several major research institutes that drive its scientific endeavors, including the Erasmus MC Cancer Institute, which integrates research across fundamental, translational, and clinical domains to advance cancer understanding and control. The Department of Neurosciences conducts and clinical work in neurosciences. Additionally, the Genomics Core Facility supports biomedical initiatives by providing advanced sequencing, , and services to facilitate genomic research and personalized approaches in . The institution's research strategy for 2023–2029, titled "Focus on Societal Challenges as Driver on Research," prioritizes areas with high societal impact, aligning with Erasmus MC's role as a tertiary care center. Key focus areas include , through the development of biomarkers and individualized risk models for tailored interventions; infectious diseases, addressing emerging threats via prevention, diagnostics, and mitigation efforts, supported by the Pandemic & Disaster Preparedness Center; and health innovation, encompassing technologies, e-health solutions, and sustainable healthcare practices. Complementing these efforts, the Research Intelligence unit at Erasmus MC delivers data-driven strategic support to leadership by analyzing research on , networks, portfolio, and metrics. This unit enables informed decision-making to optimize resource allocation and enhance overall research efficiency. These elements integrate with educational programs to train researchers in these priority domains.

Major Achievements and Collaborations

Erasmus MC has made significant contributions to research, particularly in understanding mechanisms in tumors. In 2025, researchers led by Chaudhuri at the Erasmus MC identified a novel mechanism by which BRCA2-deficient tumors develop resistance to , revealing how the protein FIGNL1 inhibits and allows these tumors to repair damage despite BRCA2 mutations. This discovery, published in Science, explains why some BRCA2-mutated cancers evade treatments like and platinum-based , potentially paving the way for strategies to reverse this resistance. In neurodegenerative disease research, Erasmus MC has advanced biomarker development for Parkinson's disease. A 2025 study identified a blood-based DNA damage signature that predicts disease progression, correlating with neuronal loss in the and offering a non-invasive tool to forecast symptom severity and guide personalized interventions. This biomarker highlights aging-related mechanisms in Parkinson's pathogenesis and could enable earlier monitoring of therapeutic responses. The institution has also secured major funding to enhance research infrastructure. In 2025, a led by Erasmus MC received a €19.6 million grant from the () under the Large-Scale Research Infrastructures program to establish the Advanced Multi-Modal Imaging Centres (AMICE), focusing on innovative imaging technologies for biomedical applications such as and high-resolution . This initiative aims to integrate advanced tools across Dutch research centers, accelerating discoveries in areas like cancer and . Erasmus MC's genomic research milestones include a pioneering in 2011 with Complete Genomics, under which the company sequenced 250 DNA samples from patient studies on cancer and congenital malformations to build Erasmus MC's medicine pipeline. This collaboration, one of the early large-scale whole-genome sequencing efforts in , supported investigations into genetic variants and was later impacted by Complete Genomics' acquisition by BGI Genomics in 2013. Key collaborations have amplified Erasmus MC's impact in infectious disease research. In 2020, researchers from Erasmus MC, , and Harbour BioMed isolated a fully (47D11) that neutralizes by targeting a conserved domain of the , demonstrating cross-reactivity with SARS-CoV and potential for prophylactic use in high-risk populations. This work, published in , formed the basis for further development through partnerships including , advancing therapies against COVID-19. Erasmus MC maintains strong international and interdisciplinary ties through its affiliation with , fostering initiatives like the Convergence alliance with to address health challenges in sustainable healthcare, urban environments, and data-driven innovations. These partnerships, including joint programs in and , enhance global knowledge exchange and resource sharing across and beyond.

Patient Care

Core Services and Specialties

Erasmus MC delivers comprehensive patient care as one of the largest university medical centers in the Netherlands, encompassing emergency trauma services, general inpatient and outpatient treatments across a wide range of medical needs. As a designated Level I trauma center, it serves as the primary referral facility for severe injuries and posttraumatic complications in the Southwest Netherlands region, handling urgent cases through its dedicated emergency department that manages both adult and pediatric patients. The center operates with approximately 1,233 beds across its facilities, supporting high-volume inpatient care while facilitating outpatient consultations for routine and specialized follow-ups. Key specialties at Erasmus MC include , where advanced procedures address complex neurological conditions; , focusing on ischemic heart disease, congenital defects, and other cardiovascular disorders; pediatrics through the integrated Sophia Children's Hospital, the largest pediatric facility in the country dedicated to treating complex childhood illnesses; and via the Cancer Institute, which provides integrated care for various malignancies. These specialties emphasize top-clinical care for patients with rare diseases, acute conditions, and complex requirements, often informed by ongoing research to enhance treatment efficacy. In its national role, Erasmus MC coordinates care through partnerships in the Dutch Federation of University Medical Centers (NFU) and contributes to national sector plans for healthcare and . Regionally, it leads affiliations such as the Southwest and specialized networks for conditions like type 1, ensuring coordinated referral and multidisciplinary support across affiliated hospitals.

Innovations in Treatment

Erasmus MC has pioneered personalized approaches, particularly through its subsidiary NeOncoFRAx, established to develop targeted treatments for solid tumors. In 2025, NeOncoFRAx launched efforts to create a personalized for , utilizing synthetic protein fragments derived from neoantigens unique to each patient's tumor. This vaccine aims to stimulate the to attack cancer cells specifically, building on preclinical observations of prolonged survival in similar therapies tested in . Led by clinical technologist Casper van Eijck Jr. and professors Joachim Aerts and Nigel Kooreman, the initiative is in early development stages, with plans for clinical trials pending regulatory approvals, potentially expanding to other cancers like and colorectal if successful. In management, Erasmus MC's leadership in the European Randomized Study of Screening for (ERSPC), initiated in 1993, has demonstrated sustained mortality reductions through systematic PSA-based screening. Long-term follow-up data from over 160,000 men across eight countries, including 42,000 from , show a 13% relative reduction in deaths after 23 years (as of 2025), with the benefit sustained over time. To refine screening and minimize , researchers developed the Risk Calculator, which integrates levels with clinical factors to cut unnecessary biopsies by over 50%. Complementing this, Erasmus MC participates in the international PI-CAI challenge, validating systems for MRI-based detection of clinically significant ; results indicate AI-assisted radiologists achieve detection rates comparable to or exceeding unassisted experts, enhancing diagnostic precision in screening programs. Erasmus MC integrates research findings into clinical trials addressing chemotherapy resistance, notably in BRCA2-mutated cancers. A key example is the FUTURE trial (EudraCT 2018-002914-10), an ongoing phase II study as of November 2025 evaluating the RECAP test to select advanced breast cancer patients, including those with BRCA2 germline mutations, for talazoparib—a PARP inhibitor that exploits DNA repair deficiencies similar to those targeted by chemotherapy. The trial assesses progression-free survival and explores resistance mechanisms in homologous recombination-deficient tumors, aiming to identify responders beyond traditional genetic markers. Recent laboratory insights from Erasmus MC reveal a novel chemoresistance pathway in BRCA2-deficient cells, where alternative proteins enable DNA repair despite BRCA2 loss, informing trial designs and potential combination therapies to overcome resistance.

Notable Events and Challenges

COVID-19 Response

During the peak of the from 2020 to 2022, Erasmus MC coordinated patient intake and testing efforts across the region, serving as the primary diagnostic laboratory for from January to August 2020. As the sole testing facility initially, it processed samples from regional healthcare providers and supported rapid for symptomatic cases, enabling efficient allocation of hospital resources amid surging caseloads. To address in vulnerable communities, Erasmus MC implemented community-based walk-in testing sites in low-income neighborhoods, conducting over 10,000 tests and identifying disparities in testing influenced by socioeconomic factors. In collaboration with , Erasmus MC contributed to pivotal research on neutralizing antibodies, discovering a human (47D11) in early that blocks viral infection by targeting the spike protein's receptor-binding domain. This work, extended through partnerships with Harbour BioMed and , advanced therapeutic candidates for prevention and treatment, with preclinical studies demonstrating protection against in animal models. To manage infrastructure demands, Erasmus MC expanded ICU surge capacity through predictive algorithms developed in partnership with , which analyzed patient data to forecast deterioration and prioritize transfers, thereby improving outcomes for severe cases. Complementing these adaptations, the institution led vaccination efforts by evaluating immunogenicity in high-risk groups, such as cancer patients undergoing treatment, confirming robust responses comparable to healthy controls and informing prioritized rollout strategies in the region.

Security Incidents and Other Developments

On September 28, 2023, a tragic shooting incident occurred at the Erasmus MC Education Centre in , where a 33-year-old medical student, Fouad L., fatally shot lecturer before setting fire to the building. This event was part of a broader that day, including the earlier killing of a mother and her 14-year-old daughter in a nearby apartment, resulting in three deaths total. Fouad L. was arrested shortly after and later faced charges of , , and weapons possession; in January 2025, prosecutors demanded a 30-year sentence, with the trial revealing his initial plans for a larger attack on students. On February 21, 2025, Fouad L. was sentenced to . The shooting led to the immediate closure of Erasmus MC's education buildings, disrupting classes and prompting a multi-team response that underscored the need for enhanced campus safety protocols. In response to the incident, Erasmus MC implemented support measures for affected staff and students, including trauma processing sessions and memorial events, while the broader aftermath highlighted organizational resilience through coordinated recovery efforts. A year later, in 2024, the Education Centre reopened with commemorative lighting projections symbolizing unity, though the institution continued addressing the ongoing psychological impact on the community. In 2024, the Erasmus MC Technology Transfer Office (TTO) achieved notable milestones in fostering innovation and entrepreneurship, securing investment deals for three spin-off companies to advance medical technologies. Pan Cancer T, developing T-cell therapies for solid tumors, raised €4.25 million in a seed extension round in July to progress its lead product through preclinical studies. Spatium Medical, focused on minimally invasive gynecology tools, closed a €5 million financing round in September, led by investors including InnovationQuarter and Demcon Investment Partners, to support clinical validation and market entry. Kaminari Medical, innovating in intravascular imaging via photoacoustic and ultrasound integration, completed a €3.8 million seed round in October, backed by Graduate Entrepreneur and Demcon, to accelerate prototype development and gather clinical evidence. These deals exemplified the TTO's role in stimulating entrepreneurship, further supported by expansions to the Erasmus MC Incubator and new regional collaborations for project incubation. Erasmus MC advanced its sustainability initiatives through the Koers28 strategic plan for 2024–2028, which emphasizes proactive solutions to societal healthcare challenges, including environmental and practices in medical operations. Key efforts under Koers28 include dedicated research programs on , such as the ESCH-R initiative promoting sustainable healthcare models, and events like the Duurzame Dagen in November 2025 to integrate eco-friendly innovations across patient care and research. Complementing this, the Masterplan 2050, approved by the Rotterdam municipal council in February 2025, envisions transforming the Erasmus MC Campus into a sustainable urban hub by 2050, with expansions up to 100,000 square meters for integrated healthcare, technology, and to reduce carbon footprints and enhance .

References

  1. [1]
    About Erasmus MC
    At Erasmus MC we work on top-clinical care for patients with complex care needs, rare diseases, or acute needs for care and treatment. Education We work on ...
  2. [2]
    Annual report and financial statements - Erasmus MC
    Erasmus MC's 2024 result was €71.7 million, with €2.5 billion in revenue, and €700 million in investments for new facilities.
  3. [3]
    Fitch Affirms Erasmus MC at 'AAA'; Outlook Stable
    Dec 3, 2024 · Erasmus MC's patient base is diverse, with over 192,000 unique patients in 2023 in the area it serves and as such, has demonstrated low ...Missing: size rankings
  4. [4]
    Campus | Erasmus MC | Erasmus University Rotterdam
    In 2018 the old hospitals were replaced with a state-of-the art single-patient 1,000 bedroom hospital. Erasmus MC is committed to a healthy population and ...
  5. [5]
    European University Hospital Alliance: EUHA
    Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe, boasting 3,099 beds and approximately 100 departments and ...About the Alliance · Strategic Plan · EUHA Advice Programme · Research Leads
  6. [6]
    Erasmus MC: Patient care
    Welcome to Erasmus MC in Rotterdam. We stand for a healthy population and excellent care through scientific research and education.Departments and centers · About Erasmus MC · Research groups/labs · Staff portal
  7. [7]
    Erasmus MC - University hospital in Rotterdam, Netherlands
    Mar 29, 2025 · Erasmus MC operates as a medical center with 1,233 beds, 39 operating rooms, and 121 intensive care units in Rotterdam's central district.Missing: theaters | Show results with:theaters
  8. [8]
    Contact details and directions - Erasmus MC
    On this page you will find addresses, telephone numbers and information on how to reach Erasmus MC by public transport and car.
  9. [9]
    Advantech Co-Creation Builds Intelligent Operati
    Mar 18, 2020 · The program originated in 2017, when the Erasmus Medical Center built a new medical facility with 26 new operating rooms. In the preparatory ...Missing: beds 39 121
  10. [10]
    a Step Forward in the Development of Erasmus MC Campus - News
    Feb 25, 2025 · We are thrilled to announce that the Masterplan 2050 for the Erasmus MC Campus has been confirmed by the Rotterdam municipal council!Missing: 2024 | Show results with:2024
  11. [11]
    New Erasmus MC Campus to boost healthcare in Rotterdam
    Dec 11, 2024 · The project aims to integrate green spaces, sustainable design, and enhanced connectivity within the heart of Rotterdam.
  12. [12]
    Changed parking fees visitors Erasmus MC - News
    Dec 5, 2024 · The municipality of Rotterdam will increase parking fees in all car parks (including the Museumpark garage) as of 1 January 2025.
  13. [13]
    Erasmus MC | Erasmus University Rotterdam
    Erasmus MC is an academic hospital and the medical faculty of Erasmus University Rotterdam. Please note: The Education Center will be renovated from July 2024.
  14. [14]
    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM ...
    Erasmus Universitair Medisch Centrum Rotterdam (EMC) is the largest of the eight university medical centres in The Netherlands.
  15. [15]
    Erasmus University Rotterdam | World University Rankings | THE
    23rd. ranking clinical health. Medical and Health 202552nd. ranking law. Law ... Copyright © 2025 THE - Times Higher Education. All rights reserved. Leiden ...About Erasmus University... · Rankings · Discover Similar...
  16. [16]
    Erasmus MC cleared to acquire ADRZ hospital - ACM
    Apr 21, 2017 · The Netherlands Authority for Consumers and Markets (ACM) has cleared the acquisition of the Admiraal de Ruyter Hospital (ADRZ) by the Erasmus University ...Missing: national coordination
  17. [17]
    Rotterdam's Superdiversity from a Historical Perspective (1600–1980)
    Nov 27, 2018 · This chapter analyses the major trends in Rotterdam's migration history in three periods: the early-modern period (1600–1800), the era in which the Working ...
  18. [18]
    The history of our medical school - Erasmus Universiteit Rotterdam
    The Stichting Klinisch Hoger Onderwijs developed into to the Medische Faculteit Rotterdam, founded in 1966, and finally became part of Erasmus University ...Missing: date | Show results with:date
  19. [19]
    Research Mission and Strategy - Erasmus MC
    4. Erasmus MC will develop innovative methods and technologies that contribute to tailored healthcare, including accessibility and sustainable healthcare.<|control11|><|separator|>
  20. [20]
    Our new site - Erasmus MC
    The new site began operations in May 2018, features single rooms with private bathrooms, natural light, and is sustainable and safe. Old buildings will be ...
  21. [21]
    Dutch King opens new Erasmus MC
    Sep 6, 2025 · Dutch King Willem-Alexander officially opened the new Erasmus Medical Centre on Thursday September 6th. During a festive meeting on the ...
  22. [22]
    None
    ### Summary of Koers28 Strategy (Erasmus MC)
  23. [23]
    Sustainability in Healthcare - Research at the Erasmus MC - ESCH-R
    Jul 8, 2025 · Sustainability in Healthcare ... Koers28 programme. Koers28 is the five-year strategy for the period 2024–2028 of the Erasmus MC, […].
  24. [24]
    Strategie: Koers28: De toekomst begint met doen
    Een koers waarmee we proactief bijdragen aan oplossingen voor de grote maatschappelijke uitdagingen die op het Erasmus MC en de samenleving afkomen. Een koers ...
  25. [25]
    Prof. Stefan Sleijfer reappointed as dean and chair of the Executive ...
    The Executive Board of Erasmus University Rotterdam has reappointed Prof. Stefan Sleijfer as dean of the Faculty of Medicine and Health Sciences.<|control11|><|separator|>
  26. [26]
    Dr. J.G. (Joke) Boonstra - Erasmus MC
    Joke Boonstra is vice chairman of the Executive Board of the Erasmus MC. She studied medical biology at the University of Amsterdam and obtained her PhD at ...
  27. [27]
    Paul Boomkamp reappointed as director and CFO Erasmus MC
    Oct 25, 2024 · The reappointment takes effect from 1 November 2024. ... Paul Boomkamp reappointed as director and CFO Erasmus MC. October 25, 2024.
  28. [28]
    Ir. D.M. (Dirk) Schraven - Erasmus MC
    Dirk Schraven is a member of the Executive Board. His work focuses on innovation, digitalization and major transformation projects including real estate.<|control11|><|separator|>
  29. [29]
    [PDF] Introduction Erasmus MC, Rotterdam - Korea-EU Research Centre
    Supervision rates (staff:students). Medicine (preclinical). 9:10. Research Master (MSc)* 1:1. PhD*. 2:1. Only Dutch Med School offering all medical specialties.
  30. [30]
    Project partner · Erasmus MC - ITEA 4
    The organization consists of over fifty departments. Each department contributes to Erasmus MC's three core tasks: patient care; research; education. Our ...Missing: administrative structure
  31. [31]
    Departments and centers - Erasmus MC
    Departments and centers (58) · Erasmus MC > Research > Department Allergology, Internal Medicine · Erasmus MC > Research > Department Anesthesiology · Erasmus MC > ...Missing: administrative structure organization
  32. [32]
    Erasmus MC - Network - PURE.EUR.NL.
    Internal Medicine · Public Health · Cardiology · Epidemiology · Pediatrics · Surgery · Radiology & Nuclear Medicine · Neurology.Missing: divisions | Show results with:divisions
  33. [33]
    Education Policy and Advice - Erasmus MC
    The Education Policy and Advice department is responsible for the organization, planning, and administration of the medical training program.Missing: divisions clinical
  34. [34]
    Institute of Medical Education Research Rotterdam (iMERR)
    ... medical students and residents acquire appropriate clinical reasoning skills. What do we investigate? These are ... ©2025 Erasmus MC. logo erasmus mc.
  35. [35]
    Medical Microbiology & Infectious Diseases - PURE.EUR.NL.
    Erasmus MC other · Erasmus MC. Organisational unit: Department. 107 shared ... Admiraal de Ruyter Hospital. External organisation: Medical. 4 shared research ...
  36. [36]
    Bachelor Geneeskunde | Erasmus University Rotterdam
    Bachelor of Medicine: Making people who are sick better, from diagnosis to treatment. Discover the programme.Missing: details | Show results with:details
  37. [37]
    What is a 6-year MD program according to European standards?
    Mar 15, 2021 · In most European countries you need to do a bachelor of medicine followed by a master in medicine. Both take 3 years, so it is six years in total.
  38. [38]
    Starting next year, Erasmus MC will prepare students for a new ...
    Apr 29, 2024 · The degree programme in Medicine has been completely overhauled. After some seven years of preparation, the first batch of students will start in the new 2030 ...
  39. [39]
    Study Programmes | Erasmus MC | Erasmus University Rotterdam
    Bachelor of Medicine: Making people who are sick better, from diagnosis to treatment. Discover the programme. Bachelor; 3 years; Dutch.Missing: details | Show results with:details
  40. [40]
    Bachelor programmes - Erasmus Universiteit Rotterdam
    Bachelor programmes, Master programmes, Research Masters & Post Master, Postgraduate programmes, PhD Tracks, Scholarships, Practical matters, Rules and ...Missing: details | Show results with:details
  41. [41]
    Erasmus MC Academy
    Our main task is providing professional development for all healthcare workers. We offer you the opportunity to improve and expand your patient care knowledge ...
  42. [42]
    Erasmus MC Graduate School
    These research master programs and PhD tracks within Erasmus MC are offered through Erasmus University Rotterdam (EUR).
  43. [43]
    Research Masters - Erasmus MC Graduate School
    These research master programs and PhD tracks within Erasmus MC are offered through Erasmus University Rotterdam (EUR).
  44. [44]
    How to apply for a PhD position - Erasmus Universiteit Rotterdam
    International applicants to PhD programmes at Erasmus MC Graduate School need to provide a proof of English language proficiency to qualify for admission.
  45. [45]
    PhD programmes | Erasmus University Rotterdam
    All faculties have their own doctorate programme, which normally amounts to a four-year track during which you perform research on a particular subject under ...Why pursue a PhD in the... · Rankings · Why the NetherlandsMissing: MC | Show results with:MC
  46. [46]
    Future PhD candidates | Working at | Erasmus University Rotterdam
    Every year, more than 300 academics obtain their PhD at Erasmus University Rotterdam. Discover all that you have to take in consideration when doing a PhD.
  47. [47]
    Application - Health Sciences - Erasmus Universiteit Rotterdam
    The deadline for your application is 1 April 2026, 23.59 hrs of the year you wish to start the programme.
  48. [48]
    The institute for Medical Education Research Rotterdam
    The iMERR, located at Erasmus MC, Rotterdam, researches all aspects of medical education, from student selection to post-initial education.Missing: administrative | Show results with:administrative
  49. [49]
    Cancer Institute: Research - Homepage - Erasmus MC
    Research in the group is focused on exploiting antigen presentation for immunotherapy to cure gastrointestinal and hepatic diseases.Missing: key Neurological
  50. [50]
    Neurosciences - Department - Erasmus MC
    Departments and research centers · Developmental Biology · Expertise center ENCORE · Genetic Identification · Molecular Genetics · Neurosciences · Psychiatry · What do ...Missing: key institutes
  51. [51]
    Home
    ### Summary of Biomedical Genomics Efforts at Erasmus MC
  52. [52]
    Research Intelligence - Erasmus MC
    Research Intelligence provides strategic decision support by analyzing research information, focusing on impact, networks, portfolio and performance.
  53. [53]
    FIGNL1 inhibits homologous recombination in BRCA2 deficient cells ...
    Oct 30, 2025 · Tumor cells with BRCA2 mutations show RAD51 loading and HR deficiencies (12–15), which are targets for chemotherapeutics such as poly(adenosine- ...
  54. [54]
    BRCA2 research reveals a novel mechanism behind chemoresistance
    Oct 30, 2025 · ... Erasmus MC Cancer Institute has now uncovered a mechanism by which BRCA2-deficient tumors develop this resistance. The proteins BRCA2 and ...
  55. [55]
    A blood-based DNA damage signature in patients with Parkinson's ...
    Sep 5, 2025 · Our study sheds light on an aging-related mechanism in PD pathogenesis and identifies potential markers of disease progression, providing a ...
  56. [56]
    Biomarker may predict Parkinson's disease progression
    Oct 8, 2025 · Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson's disease.
  57. [57]
    https://amazingerasmusmc.com/biomedical/nearly-e20-million-to-drive-innovation-in-imaging-technology/
  58. [58]
    Latest Cofa News - Erasmus MC
    Nearly €20 Million to Drive Innovation in Imaging Technology. A national consortium led by Erasmus MC has been awarded €19.6 million through the NWO Large-Scale ...Missing: grant 2023
  59. [59]
    Erasmus University Medical Center Partners With Complete
    This agreement calls for Complete Genomics to sequence 250 DNA samples for Erasmus MC research studies over the next 12 months. Samples will come from patients ...
  60. [60]
    Erasmus University Medical Center Partners With Complete ...
    May 19, 2011 · This agreement calls for Complete Genomics to sequence 250 DNA samples for Erasmus MC research studies over the next 12 months. Samples will ...
  61. [61]
    AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical ...
    Jun 5, 2020 · AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center announce collaboration to develop monoclonal antibody therapy to prevent and treat COVID- ...
  62. [62]
    Convergence | Erasmus University Rotterdam
    Erasmus University Rotterdam joins forces with researchers from Erasmus MC and TU Delft to work on sustainable healthcare. Tuesday 31 Oct 2023; General.
  63. [63]
    Collaborations - Erasmus MC
    Erasmus MC collaborates with NFU, Convergence, Medical Delta, EUHA, and Health-RI, among others, to strengthen medical research.
  64. [64]
    Academic Center for Trauma - Rotterdam - Erasmus MC
    Erasmus MC is the largest governmentally assigned Dutch level I Trauma Center, and referral center for patients with posttraumatic complications ...Go Directly To · Research Activities · Care Activities
  65. [65]
    Emergency department - Erasmus MC
    Patients don't plan a visit to the emergency department, patients come because they have to. They have a health issue or injury that requires emergency ...
  66. [66]
    Erasmus Medical Center | Case Study - Leviton
    As the largest university medical center and the second largest hospital in the Netherlands, Erasmus MC is home to more than 1,320 beds found in three locations ...Missing: employees | Show results with:employees
  67. [67]
    Neurosurgery - Department - Erasmus MC
    Patient care. Erasmus MC Specialised care for everyone. Sophia Children's Hospital Health care for children. Cancer Institute Health care for cancer ...Missing: specialties cardiology pediatrics
  68. [68]
    Cardiology - Department - Erasmus MC
    The department is involved in teaching, research and treatment of cardiovascular diseases with 5 focus areas: ischemic cardiovascular disease, congenital or ...Missing: specialties | Show results with:specialties
  69. [69]
    About Erasmus MC Sophia
    We are an innovative children's hospital that has been in the heart of Rotterdam for over 150 years. An university medical center where specialised top care.
  70. [70]
    Traumacentrum Zuidwest Nederland, Erasmus MC, Rotterdam
    Oct 21, 2019 · Trauma Care at Erasmus MC and Trauma Center Southwest Netherlands. The Traumacentrum Zuidwest Nederland is part of the trauma network ...
  71. [71]
    New Erasmus MC Subsidiary Develops Personalized Immunotherapy
    a personalized cancer vaccine — is intended for patients with pancreatic cancer. By: Joyce de Bruijn 28 July 2025. Share.Missing: 2023 | Show results with:2023
  72. [72]
    Screening reduces prostate cancer mortality, even after more than ...
    Oct 30, 2025 · An elevated PSA does not always mean prostate cancer. That is why researchers at Erasmus MC developed the Prostate Cancer Risk Calculator.
  73. [73]
    https://www.nejm.org/doi/full/10.1056/NEJMoa2503223
  74. [74]
    EU Clinical Trials Register
    Jul 17, 2019 · Erasmus MC Cancer Institute. B.5.2, Functional name of contact point ... BRCA2 germline mutation The site of the metastatic lesion (or ...
  75. [75]
    https://amazingerasmusmc.com/biomedical/new-mechanism-in-brca2-tumors-discovered-why-chemotherapy-sometimes-fails/
  76. [76]
    Ever alert to the next threat to human health: a conversation with Dr ...
    Jan 24, 2023 · Can you tell us what role the Erasmus MC laboratories have played in testing for SARS-CoV-2, the virus that causes COVID-19 disease? From ...
  77. [77]
    Community-based SARS-CoV-2 testing in low-income ...
    Two to eleven test facilities operated consecutively in three low-income neighbourhoods in Rotterdam, offering the options of walk-in or appointments.
  78. [78]
    A human monoclonal antibody blocking SARS-CoV-2 infection
    May 5, 2020 · This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.
  79. [79]
    Freeing up ICU-capacity with a predictive algorithm - Deloitte
    Together with medics from Erasmus MC, Rotterdam, our consultants, data scientists and software developers forged an algorithm that predicts whether a Covid-19 ...Missing: testing | Show results with:testing
  80. [80]
    COVID-19 vaccine works well during treatment of solid tumors
    Sep 20, 2021 · ... COVID-19 vaccine. A study conducted by MC Groningen, Erasmus MC in Rotterdam, and the Netherlands Cancer Institute in Amsterdam, in ...
  81. [81]
    Three dead after shootings erupt in Dutch city, police say - CNN
    Sep 28, 2023 · A 32-year-old student has been arrested after a “targeted” shooting rampage in the Dutch city of Rotterdam left three people dead on Thursday.
  82. [82]
    Medical student is held in custody after three people die ... - The BMJ
    Oct 4, 2023 · A medical student has been remanded in custody in the Netherlands after the fatal shooting of three people in Rotterdam on 28 September.
  83. [83]
    A year after the attack, the Education Centre feels like home again ...
    Sep 26, 2024 · Later, he moved to Erasmus MC, where he killed lecturer Jurgen Damen, later L. set fire to the Education Centre. Medical student Fouad L. is ...
  84. [84]
    Student gunman kills three in Rotterdam university shooting | Reuters
    Sep 28, 2023 · A gunman killed three people in the Dutch city, shooting a local woman and her daughter in their home then storming into a classroom of the ...
  85. [85]
    Prosecutor demands 30 years in prison against shooter at Erasmus ...
    Jan 30, 2025 · Fouad L. killed three people and set fire to his home and the Erasmus MC in Rotterdam on September 28, 2023.
  86. [86]
    Education buildings Erasmus MC unusable after shooting incident
    Sep 29, 2023 · Following the shooting incident at the hospital, in which teacher Jurgen Damen was killed, both teaching buildings are currently unusable.
  87. [87]
    https://www.erasmusmagazine.nl/en/2023/09/29/education-buildings-erasmus-mc-unusable-after-shooting-incident/
  88. [88]
    Erasmus MC remembers victims of fatal shooting on one-year ...
    Sep 28, 2024 · A lecturer of the Erasmus MC lost his life at the shooting on September 28, 2023. The 33-year-old suspect, a medical student, had also shot ...
  89. [89]
    Highlights from 2024 that we're proud of! - News - Erasmus MC
    Jan 20, 2025 · Investment deals for three of our spin-offs: Pan Cancer T, Spatium Medical, Kaminari Medical. Collaboration agreement for our socially ...
  90. [90]
    4.25 Million in Seed Extension Round | Pan Cancer T
    Jul 11, 2024 · Rotterdam, July 11 2024 Pan Cancer T B.V., a pioneering biotech start-up developing next-generation T cell therapies for solid cancer ...
  91. [91]
    Spatium Medical B.V. closes €5 Million financing round to bring ...
    Sep 17, 2024 · Rotterdam-based company Spatium Medical BV, a pioneering MedTech spinoff from Erasmus MC, has successfully closed a €5 million financing round.
  92. [92]
    Advancing Next Generation Intravascular Imaging - Kaminari Medical
    Kaminari Medical, an innovator in intravascular imaging technology, has successfully closed a € 3.8 M funding round to accelerate product development.
  93. [93]
    New seed investment: Kaminari Medical - Graduate Entrepreneur
    Oct 15, 2024 · Kaminari Medical, a Rotterdam-based innovator, received €3.8M funding for its intravascular imaging tech using photoacoustics and ultrasound to ...
  94. [94]
    ESCH-R WP4 Roadmap Session – Building the future of circular ...
    Oct 29, 2025 · On November 10 and 11, the Duurzame Dagen are taking place as part of the Koers28 programme. Koers28 is the five-year strategy for the period ...
  95. [95]
    Green light for the development of Erasmus MC Campus
    Mar 3, 2025 · The Erasmus MC Masterplan 2050 has been approved by the Municipality of Rotterdam. This will allow the further development of the Erasmus MC ...Missing: 2024 | Show results with:2024